A health-agency windfall includes funding for two promising clinical trials, one focusing on prevention and the other on early treatment
Spinal scans reveal the mechanism by which intense thinking can block pain receptors in the nervous system
To the great surprise of many, psilocybin, a potent psychedelic, reduces brain activity
As the number of cases of the paralytic disease fall, world health officials have to grapple with a vexing problem: a component of the most widely used polio vaccine now causes more disease than the virus it is supposed to fight
The caustic imprint of a traumatic memory may fade or vanish with new drug and behavioral therapies
Letters to the Editor about the January/February 2012 issue of Scientific American Mind
Gonorrhea, once a minor illness, is developing resistance to the last category of drugs that still works against it and could become untreatable
A look at some of the most promising medical devices now in development
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
Listen to this Podcast
